Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision [Yahoo! Finance]
Impact BioMedical, Inc. (IBO)
Company Research
Source: Yahoo! Finance
is also pursuing new products to expand its portfolio, with its Laetose and 3F platforms available for immediate partnering. The company reported net income of $4,241,000, with year-to-date net income of $2,363,000 as of September 30, 2024, and an increase in shareholder equity from $28.26 million to $34.56 million, representing growth of approximately $0.54 per share. Impact BioMedical discovers, confirms, and patents unique science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness, in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. Impact BioMedical successfully launched its IPO, raising $4.5 million in capital, with 1.5 million shares freely tradable on the NYSE, and the remaining 10 million shares restricted from trading until March 2025. The company is well-positioned to drive long-term value for its shareholders, and will provide
Show less
Read more
Impact Snapshot
Event Time:
IBO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IBO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IBO alerts
High impacting Impact BioMedical, Inc. news events
Weekly update
A roundup of the hottest topics
IBO
News
- Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic VisionGlobeNewswire
- Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory DiseaseGlobeNewswire
- Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and AffiliatesGlobeNewswire
- Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent IssueGlobeNewswire
- Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and GrowthGlobeNewswire
IBO
Sec Filings
- 11/12/24 - Form 10-Q
- 9/19/24 - Form 4
- 9/18/24 - Form 4
- IBO's page on the SEC website